Money Talks, Nobody Squawks –
Nov. 27, 2018 – Last week I discussed the many issues surrounding the “chatter” of a Kohlberg, Kravis, and Roberts & Co. (NYSE: KKR) bid to purchase Acadia Healthcare Company, Inc. (Nasdaq: ACHC). Reports by Josh Kosman of the New York Post and David Faber of CNBC seem to conflict. So, given the murky waters of merger and acquisition buzz, it would seem fair to consult the leadership at Acadia. However, on the 2018 Q3 earnings call, my request to ask a question was not honored, and CEO Joey Jacobs prefaced the “buyout buzz” with a ‘no-comment’ policy, saying:
